TEST #3 Hon Multiple Sclerosis Flashcards Preview

Neuro 2 > TEST #3 Hon Multiple Sclerosis > Flashcards

Flashcards in TEST #3 Hon Multiple Sclerosis Deck (14)
Loading flashcards...
1
Q

Definition of MS

A

– A disorder of the brain and spinal cord characterized by a tendency for periods of increasing and decreasing symptoms and signs (exacerbations & remissions), which RESULT FROM LOSS OF NERVE TRACT INSULATION (myelin) at multiple sites in the CNS.

2
Q

M.S. Patients can present with almost any Neurologic Symptom, however, the following as some COMMON Ones:

A
– Paresthesias
– Gait disturbance (e.g. transverse myelitis) 
– Weakness
– Visual loss (e.g. optic neuritis)
– Urinary difficulty
– Dysarthria
– Hemiparesis
3
Q

There are four types of M.S.:

A

1) RELAPSING REMITTING (45-50%)
2) SECONDARY PROGRESSIVE (20-25%) – note that these patients BEGIN their disease process in the RELAPSING REMITTING category.
3) PRIMARY PROGRESSIVE (15-20%)
4) BENIGN (10-15%)

4
Q

The following can be said about MS:

A

– M.S. is a disorder of the central nervous system.

– Most M.S. patients are diagnosed in their 20’s and 30’s.

– This disorder is generally characterized by PERIODS of EXACERBATION and REMISSION.

– NO SINGLE TEST CAN CONFIRM THE DIAGNOSIS of M.S., however multiple studies can be
used to help make the diagnosis.

5
Q

What causes MS?

A

– Essentially unknown

– Probably some GENETIC SUSCEPTIBILITY (3-5% lifetime risk of developing M.S. if you
have a first degree relative with M.S.)

– Perhaps a childhood event or illness that sensitizes the immune system to attack CNS myelin, followed by an adult event triggering the disease process – e.g. viral infection, post-partum period.

6
Q

Epidemiology of MS

A

– Affects women more than men (1.5:1), with women generally having a more
favorable course

– Onset of disease between age 15-50 (average age of onset 29) years. In general,
earlier onset is a more favorable prognostic feature.

– Geographic distribution:
a) TROPICAL ZONES: 5-10 per 100,000

b) TEMPERATE ZONES: 50 per 100,000!!!!!!!!!!!
i) Risk determined BEFORE AGE 14!!!!!!!!!!!!!!!!!!

7
Q

Studies used to make the Diagnosis of MS

A

– MRI of the head, C & T spine!!!!!!!!!
a) Typically see OVOID LESIONS of HIGH SIGNAL on T2WI in the PERIVENTRICULAR WHITE MATTER and in the spinal cord. Acute lesions may enhance.

– Multimodality evoked potentials (SSEP’s, VEP’s, BAER)

– Lumbar puncture for CSF analysis:
• **Presence of OLIGOCLONAL BANDS &/or INCREASED IgG ——-> index/synthesisratearethetypical findings in ——-> M.S. patients

8
Q

Description of MS

A
  • M.S. is diagnosed by MULTIPLE LESIONS OVER SPACE AND TIME!!!!!
9
Q

Drugsusedfor“maintenance”inM.S.(todecreasethefrequencyand severity of exacerbations and slow the progression of the disease):

A
  • Avonex, Rebif (Interferon Beta-1A)
  • Betaseron (Interferon Beta-1B)
  • Copaxone (Glatirimer Acetate)
  • Tysabri (natalizumab)
  • Gilenya (fingolimod)
  • Aubagio (Teriflunomide)
  • Tecfidera (Dimethyl fumarate)
  • Lemtrada (Alemtuzumab)

*** In general, these medications are used in patients with RELAPSING FORMS of M.S. (NOT Primary Progressive)!!!!!!

10
Q

Medication used to treat an acute exacerbation in MS

A

– High dose CORTICOSTEROIDS (Solumedrol – 1 gram I.V. daily for 3-5 days followed by PREDNISONE TAPER)

– This generally REDUCES the length of the exacerbation, but is not thought to change the overall outcome of it.

11
Q

Differential Diagnosis

A

– It is nearly impossible to differentiate a first time M.S. attack from a post-infectious or post-immunization encephalomyelopathy (A.D.E.M.
– Acute Disseminated Encephalomyelitis).

– ADEM should never recur, however. If the patient develops future symptoms or new lesions on neuroimaging (MRI), M.S. is the more likely diagnosis.

– AUTOIMMUNE DISEASE – e.g. SLE with cerebritis or CNS vasculitis or
Polyarteritis Nodosa with transverse myelitis

– Devic’s disease (Neuromyelitis Optica)

– B12 deficiency

– Lymphoma or Leukemia with CNS involvement

– Spinocerebellar ataxias

– Vascular malformations – e.g. spinal cord AVM

– Infections – e.g. HIV, HTLV-1, EBV, CMV, West Nile Virus, Lyme
Disease, Syphilis

– Granulomatous Disease – e.g. Sarcoidosis

– Metachromatic leukodystrophy, adrenomyeloleukodystrophy

12
Q

MS and Medications

A
  • Although immunomodulatory medications are helpful in improving the overall disease progression, there is NOTHING TO STOP THE DISEASE PROCESS.
  • Much effort must be made to treat the symptoms of M.S.
13
Q

Things used for Symptom Treatment

A

• SPASTICITY:
– Baclofen (oral or intrathecal), tizanadine, diazepam, carbamazepine, BoTox
injections, dantrolene

• INTENTION TREMOR:
– Propranolol, primidone, clonazepam

• URINARY URGENCY (Spastic Bladder)
– Oxybutinin, Petrol LA

• URINARY RETNETION/ HESITANCY:
– bethanechol

• PAINFUL DYSESTHESIAS:
– Carbamazepine, oxcarbamazepine, gabapentin, phenytoin, baclofen

• FATIGUE:
– Amantadine, modafinil, armodafinil, fluoxetine, bupropion, methylphenidate, pemoline, exercise

*** Although there is no cure for M.S., most patients can be MANAGED WELL with early, aggressive intervention.

14
Q

Devices Disease

A

AKA Neuromyelitis Optica (NMO)!!!!!!!!!

  • Sometimes considered a “variant” of M.S., but probably a different entity.
  • Characterized by INFLAMMATION and DEMYELINATION of Optic Nerves and Spinal Cord (often long segments of spinal cord) with relative sparing of brain.
  • Can use fairly sensitive and specific testing for NMO (Aquaphorin) antibodies in blood and CSF.
  • Treatment is generally STEROIDS &/or plasma exchange, followed by immunosupression (e.g. azothiaprine, mycophenolate mofetil, or rituxumab).